How many stocks are there of Medios?
The current number of stocks of Medios is 23.81 M undefined.
Medios Stocks 2024
Medios Stocks
23.81 M
Ticker
ILM1.DE
ISIN
DE000A1MMCC8
WKN
A1MMCC
In 2024, Medios had 23.81 M outstanding stocks, a 0% change from the 23.81 M stocks in the previous year.
The Medios Stocks history
| YEAR | NUMBER OF STOCKS (undefined EUR) |
|---|---|
| 2029e | 23.81 |
| 2028e | 23.81 |
| 2027e | 23.81 |
| 2026e | 23.81 |
| 2025e | 23.81 |
| 2024e | 23.81 |
| 2023 | 23.81 |
| 2022 | 23.76 |
| 2021 | 20.16 |
| 2020 | 16.01 |
| 2019 | 14.91 |
| 2018 | 13.78 |
| 2017 | 12.77 |
| 2016 | 12.42 |
| 2015 | 0.89 |
| 2014 | 0.46 |
| 2013 | 0.5 |
| 2012 | 0.5 |
| 2011 | 0.5 |
| 2010 | 0.5 |
| 2009 | 0.3 |
| 2008 | 0.3 |
| 2007 | 0.5 |
| 2006 | 0.5 |
| 2005 | 0.5 |
| 2004 | 0.5 |
Medios shares outstanding DE000A1MMCC8 · A1MMCC
The number of shares was Medios in 2023 — This indicates how many shares 23.806 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
25 Years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Medios earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Medios's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Medios’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Medios's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2004 | 500,000 Aktien |
| 2005 | 500,000 Aktien |
| 2006 | 500,000 Aktien |
| 2007 | 500,000 Aktien |
| 2008 | 300,000 Aktien |
| 2009 | 300,000 Aktien |
| 2010 | 500,000 Aktien |
| 2011 | 500,000 Aktien |
| 2012 | 500,000 Aktien |
| 2013 | 500,000 Aktien |
| 2014 | 455,540 Aktien |
| 2015 | 892,520 Aktien |
| 2016 | 12.42 M Aktien |
| 2017 | 12.77 M Aktien |
| 2018 | 13.78 M Aktien |
| 2019 | 14.91 M Aktien |
| 2020 | 16.01 M Aktien |
| 2021 | 20.16 M Aktien |
| 2022 | 23.76 M Aktien |
| 2023 | 23.81 M Aktien |
| 2024e | 23.81 M Aktien |
| 2025e | 23.81 M Aktien |
| 2026e | 23.81 M Aktien |
| 2027e | 23.81 M Aktien |
| 2028e | 23.81 M Aktien |
| 2029e | 23.81 M Aktien |
Medios Aktienanalyse
What does Medios do?
Medios AG is a leading company in the supply of high-quality specialty preparations to patients. The company was founded in Berlin in 2004 and has been listed on the Frankfurt Stock Exchange since 2018. Medios AG quickly achieved a strong position in the German healthcare market and currently employs approximately 300 employees at multiple locations in Germany. The business model of Medios AG is based on the production and distribution of high-quality specialty preparations. These are developed and produced in close collaboration with customers such as hospitals and outpatient clinics. Medios AG's products are typically used to treat rare and chronic diseases, such as immunological diseases, cancer, and metabolic disorders. Medios AG offers a wide range of products and services. The company is divided into three areas. The first area is Medios AG's core business, the distribution of specialty preparations. This area includes the development, production, and distribution of specialty preparations. The portfolio includes, for example, medications for pain and inflammation, as well as preparations for the treatment of Parkinson's and Alzheimer's diseases. Another important aspect in the field of specialty preparations is the supply of patients with parenteral nutrition solutions. These are used in both outpatient and inpatient settings to provide care for patients with severe diseases. The second area is supply services. Here, Medios offers a comprehensive range of services to support customers in hospital care and outpatient patient care. An important aspect of this area is the support of hospitals in dealing with delegations. For example, training is offered to educate hospital staff on the management of certain diseases. The third area is clinical study support. Medios AG offers services and products to support customers in clinical studies. The range includes criteria for patient-related logistics, the delivery of placebos and blinded medications, as well as specialty preparations and parenteral nutrition solutions. In each of these areas, Medios brings its high expertise and experience to develop the best possible solutions for customers and patients. Overall, Medios AG has established itself as an important partner for the German healthcare sector. The company pursues a clear strategy focused on the development and production of specialty preparations for the treatment of serious and rare diseases. The company places the highest value on the quality and safety of its products, as well as comprehensive consultation and customer care. Medios has a strong network of partners and suppliers in the healthcare industry and is a respected contact for customers and other market participants due to its experience and expertise. Medios ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating Medios's Shares Outstanding
Medios's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in Medios’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding Medios’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in Medios’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about Medios stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of Medios are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of Medios evolved in recent years?
The number of shares of Medios has increased by 0% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. Medios as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of Medios?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does Medios pay?
Over the past 12 months, Medios paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Medios is expected to pay a dividend of 0 EUR.
What is the dividend yield of Medios?
The current dividend yield of Medios is .
When does Medios pay dividends?
Medios pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Medios?
Medios paid dividends every year for the past 0 years.
What is the dividend of Medios?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Medios located?
Medios is assigned to the 'Health' sector.
Wann musste ich die Aktien von Medios kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Medios from 7/26/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 7/26/2024.
When did Medios pay the last dividend?
The last dividend was paid out on 7/26/2024.
What was the dividend of Medios in the year 2023?
In the year 2023, Medios distributed 0 EUR as dividends.
In which currency does Medios pay out the dividend?
The dividends of Medios are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Medios
Our stock analysis for Medios Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medios Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
